MAPT and Alzheimer disease: The indole compound NC009-1 has been shown to improve cognitive deficits of 3× Tg-AD mice by upregulating the expression of APOE and tropomyosin receptor kinase A and reducing the levels of Aβ and tau in the hippocampus and cortex [140].